Metraipolis › archive › dc_ffbd6c338f84

Bivalent RSVpreF Subunit Vaccine Safety and Immunogenicity in Seropositive 2-<18 Year Olds — Europe PMC PMID:41746051

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41746051
DOI
10.3390/vaccines14020128
License (as archived)
solo-consultazione
Archived
2026-11-06T11:22:08.502Z
SHA-256 of the archived text
a8f137ffd3df752b22f18cbcabccc40455e16381e39de9525151451001b0f78d
Stable URL of this page
https://metraipolis.com/documento/dc_ffbd6c338f84

How to cite

Bivalent RSVpreF Subunit Vaccine Safety and Immunogenicity in Seropositive 2-<18 Year Olds — Europe PMC PMID:41746051 — Europe PMC (en), https://europepmc.org/article/MED/41746051 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ffbd6c338f84 (Metraipolis archive dc_ffbd6c338f84, sha256 a8f137ffd3df752b22f18cbcabccc40455e16381e39de9525151451001b0f78d)
BibTeX
@misc{dcffbd6c338f84,
  title = {Bivalent RSVpreF Subunit Vaccine Safety and Immunogenicity in Seropositive 2-<18 Year Olds — Europe PMC PMID:41746051},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41746051},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ffbd6c338f84; sha256 a8f137ffd3df752b22f18cbcabccc40455e16381e39de9525151451001b0f78d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41746051. Agents can read the archived copy with the MCP tool read_document.